Published with kind permission of MEDNOUS Wednesday 21 March 2012 Index Ventures has announced the launch of a new €150 million fund to support early-stage, research intensive companies in the life science sector. ... more »
Published with kind permission of MEDNOUS Paion AG, which has pursued diversification in its drug development, is now opting for concentration, putting its efforts behind anaesthesia, and the drug candidate, remimaz... more »
Published with kind permission of MEDNOUS. Ablynx NV is exploring all options for its rheumatoid arthritis compound, ATN-103, which was returned to the company by Pfizer in late 2011 only months after it had achieved... more »
Published with kind permission of MEDNOUS Oxford BioMedica Plc has reduced staff, appointed a new finance director, and closed an office in the US as it conserves cash in order to support the next phase of developmen... more »
Looking for special service?
Don't spend time on search!
Get applications from providers For Free